121 related articles for article (PubMed ID: 6282619)
1. Modulation of cis-platinum renal toxicity by the radioprotective agent WR 2721.
Jordan SW; Yuhas JM; Glick J
Exp Mol Pathol; 1982 Jun; 36(3):297-305. PubMed ID: 6282619
[No Abstract] [Full Text] [Related]
2. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
Yuhas JM; Culo F
Cancer Treat Rep; 1980 Jan; 64(1):57-64. PubMed ID: 6247064
[TBL] [Abstract][Full Text] [Related]
3. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
Tanaka Y; Akagi K; Hasegawa T; Nakazawa M; Harima K; Murata T; Sawada S
Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May; 43(5):700-9. PubMed ID: 6312407
[No Abstract] [Full Text] [Related]
4. Radioprotective effect of WR-2721 on haematopoiesis in mice. I. Quantitative changes in haematopoiesis.
Brezáni P; Macková N
Radiobiol Radiother (Berl); 1988; 29(5):587-93. PubMed ID: 2852382
[No Abstract] [Full Text] [Related]
5. Radioprotective effect of WR-2721 on haematopoiesis in mice. III. Changes in peripheral blood.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):603-8. PubMed ID: 2852384
[No Abstract] [Full Text] [Related]
6. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913.
Dillon J; Kennedy JC; Pottier RH; Roberts JE
Photochem Photobiol; 1988 Aug; 48(2):235-8. PubMed ID: 2851844
[No Abstract] [Full Text] [Related]
7. Radioprotective effect of WR-2721 on haematopoiesis in mice. II. Morphological changes of bone marrow and spleen.
Macková N; Brezáni P
Radiobiol Radiother (Berl); 1988; 29(5):595-601. PubMed ID: 2852383
[No Abstract] [Full Text] [Related]
8. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
Fatome M; Courteille F; Laval JD; Roman V
Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul; 52(1):21-9. PubMed ID: 3036725
[TBL] [Abstract][Full Text] [Related]
9. WR-2721, its derivatives and their radioprotective effects on mammalian cells in culture.
Mori T; Watanabe M; Horikawa M; Nikaido P; Kimura H; Aoyama T; Sugahara T
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 Jul; 44(1):41-53. PubMed ID: 6305861
[TBL] [Abstract][Full Text] [Related]
10. Reduction of tetrachloro(dl-trans)1,2-diaminocyclohexaneplatinum(IV) (tetraplatin) toxicity by the administration of diethyldithiocarbamate (DDTC), S-2(3-aminopropylamino)ethylphosphorothioic acid (WR-2721), or sodium selenite in the Fischer 344 rat.
Carfagna PF; Chaney SG; Chang J; Holbrook DJ
Fundam Appl Toxicol; 1990 May; 14(4):706-19. PubMed ID: 2163338
[TBL] [Abstract][Full Text] [Related]
11. WR-2721 inhibition of radiation-induced prostaglandin excretion in rats.
Donlon M; Steel L; Helgeson EA; Wolfe WW; Catravas GN
Int J Radiat Biol Relat Stud Phys Chem Med; 1985 Feb; 47(2):205-12. PubMed ID: 2984129
[TBL] [Abstract][Full Text] [Related]
12. Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721.
Wasserman TH; Phillips TL; Ross G; Kane LJ
Cancer Clin Trials; 1981; 4(1):3-6. PubMed ID: 6260393
[TBL] [Abstract][Full Text] [Related]
13. Radioprotective effect of WR-2721 in rabbits: a comparison with cystamine.
Kuna P; Petýrek P; Jensovský V; Melek J
Radiobiol Radiother (Berl); 1981; 22(5):644-52. PubMed ID: 6280232
[No Abstract] [Full Text] [Related]
14. Systemic factors affecting the radioprotective effectiveness of phosphorothioates.
Yuhas JM
Experientia Suppl; 1977; 27():63-70. PubMed ID: 192569
[No Abstract] [Full Text] [Related]
15. [Responses to radiation of Ehrlich ascites tumor cells in the presence of YM-08310 (=WR-2721) and/or Ro-07-0582 (in vivo, in vitro assay)].
Ebe K
Nihon Igaku Hoshasen Gakkai Zasshi; 1987 Feb; 47(2):307-17. PubMed ID: 3039456
[No Abstract] [Full Text] [Related]
16. [Experience in the search of new prolonged-action radiation-protective agents].
Grachev SA; Sverdlov AG; Kropachev EN; Nikanorova NG; Bondarev GN; Drobchenko SN
Radiats Biol Radioecol; 1996; 36(2):190-4. PubMed ID: 8673217
[TBL] [Abstract][Full Text] [Related]
17. [Effect of pharmacological agents on the radioprotective activity, toxicity and distribution of 35S-labeled aminopropylaminoethyl-thiophosphate administered perorally].
Grechka II; Belavina LP; Kalistratov GV; Zherebchenko PG
Radiobiologiia; 1979; 19(3):372-6. PubMed ID: 223190
[No Abstract] [Full Text] [Related]
18. Isoproterenol in comparison to WR-2721 as a chemoradioprotector of the rat parotid gland.
Sodicoff M; Conger AD; Pratt NE
Invest Radiol; 1979; 14(2):166-70. PubMed ID: 225291
[TBL] [Abstract][Full Text] [Related]
19. Interaction of cultured mammalian cells with WR-2721 and its thiol, WR-1065: implications for mechanisms of radioprotection.
Purdie JW; Inhaber ER; Schneider H; Labelle JL
Int J Radiat Biol Relat Stud Phys Chem Med; 1983 May; 43(5):517-27. PubMed ID: 6303973
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against fission neutron irradiation by WR-2721 or WR-151327.
Steel LK; Jacobs AJ; Giambarresi LI; Jackson WE
Radiat Res; 1987 Mar; 109(3):469-78. PubMed ID: 3031721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]